HomeROVI • VIE
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€80.90
Day range
€80.15 - €80.55
Year range
€45.82 - €84.80
Market cap
4.19B EUR
Avg Volume
6.00
P/E ratio
29.19
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 218.42M | 9.68% |
Operating expense | 73.16M | -3.79% |
Net income | 42.68M | 82.47% |
Net profit margin | 19.54 | 66.30% |
Earnings per share | — | — |
EBITDA | 55.10M | 68.56% |
Effective tax rate | 26.39% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.60M | 251.93% |
Total assets | 955.69M | 14.86% |
Total liabilities | 280.24M | 11.88% |
Total equity | 675.46M | — |
Shares outstanding | 51.15M | — |
Price to book | 6.23 | — |
Return on assets | 14.63% | — |
Return on capital | 17.68% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 42.68M | 82.47% |
Cash from operations | 85.68M | 17.18% |
Cash from investing | -26.96M | 42.84% |
Cash from financing | -7.93M | 51.42% |
Net change in cash | 48.73M | 405.88% |
Free cash flow | 47.97M | 151.65% |
About
Founded
1946
Website
Employees
1,998
